Skin Microbiome Bacteria Make Ceramides. Prebiotics Are the Key.
The skin surface hosts billions of microorganisms in a dynamic ecosystem. Not all of them are threats. Staphylococcus epidermidis (S. epidermidis) is one of the most consistently beneficial residents of healthy skin, and research published in Annals of Dermatology has detailed exactly how this bacterium participates in ceramide production, one of the most important barrier maintenance processes in the skin.
The S. epidermidis Ceramide Pathway
S. epidermidis secretes sphingomyelinase, an enzyme that cleaves sphingomyelin in the cell membranes of the stratum corneum. The byproduct of this cleavage is ceramide. The bacterium is not synthesizing ceramide itself; it is providing the enzymatic trigger that causes the skin to produce it.
When S. epidermidis populations decline, or when pathogenic bacteria like Staphylococcus aureus disrupt the microbiome balance, this sphingomyelinase secretion diminishes. The correlation is clinically visible in atopic dermatitis: affected skin shows both reduced ceramide levels and a significantly lower proportion of S. epidermidis relative to S. aureus. This pathway helps explain why microbiome disruption and barrier impairment tend to occur together.
Short-Chain Fatty Acids Activate Barrier Genes
A second mechanism runs through short-chain fatty acids (SCFAs). When beneficial skin commensals ferment carbohydrates, they produce butyrate, propionate, and acetate. These SCFAs signal skin cells to upregulate two critical barrier components: filaggrin and ceramide synthase activity.
Filaggrin is the structural protein that forms the physical scaffold of the cornified envelope. Deficiency in filaggrin, whether genetic or environmentally induced, is one of the primary drivers of elevated transepidermal water loss (TEWL) and increased allergen penetration. By stimulating filaggrin expression, SCFAs address barrier weakness at a foundational level, while simultaneously activating ceramide synthesis to reinforce the lipid matrix.
Prebiotics as the Upstream Lever
Prebiotics feed the bacteria that generate both of these effects. Applied topically, ingredients like beta-glucans, inulin, fructooligosaccharides, and galactooligosaccharides create a favorable environment for S. epidermidis and other beneficial commensals. The resulting lactic acid and SCFA production lowers skin surface pH, which has a direct antimicrobial effect against pathogens including S. aureus that prefer a higher pH environment.
Relipidium, a yeast-derived active, works differently but complementarily: it directly stimulates ceramide and cholesterol biosynthesis in keratinocytes, bridging the microbiome approach with direct barrier lipid replenishment.
Internal and External Together
Topical ceramide application has been the standard approach to barrier repair for years. What this research adds is a mechanism by which the skin can be supported in making its own ceramides, provided the right microbial environment exists.
This has practical implications in two directions. Topically, products containing prebiotic ingredients nourish the commensals that drive ceramide synthesis. Orally, gut-focused prebiotics support SCFA production that may influence skin cells through systemic circulation, though direct clinical evidence for oral prebiotics improving skin ceramide levels specifically is still accumulating.
For people dealing with dry, sensitive, or atopic-prone skin, this two-direction framing suggests that barrier care is not just about what is applied to the surface, but also about maintaining the microbial ecology that helps the surface maintain itself.